Clinicopathological significance of aberrant Notch receptors in intrahepatic cholangiocarcinoma

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 6, 2014, Pages 3272-3279

  Wu, Wen Rui ^a   Shi, Xiang De ^a   Zhang, Rui ^a   Zhu, Man Sheng ^a   Xu, Lei Bo ^a   Yu, Xian Huan ^a   Zeng, Hong ^a   Wang, Jie ^a   Liu, Chao ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

immunohistochemistry; Intrahepatic cholangiocarcinoma; Notch receptors

Indexed keywords

NOTCH RECEPTOR; TUMOR MARKER;

ADULT; AGED; BILE DUCT CARCINOMA; BILE DUCT TUMOR; BIOSYNTHESIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INTRAHEPATIC BILE DUCT; KAPLAN MEIER METHOD; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY;

ADULT; AGED; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; RECEPTORS, NOTCH; TUMOR MARKERS, BIOLOGICAL;

EID: 84904346009     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Halappa VG, Bonekamp S, Corona-Villalobos CP, Li Z, Mensa M, Reyes D, Eng J, Bhagat N, Pawlik TM, Geschwind JF and Kamel IR. Intrahepatic cholangiocarcinoma treated with local-regional therapy: quantitative volumetric apparent diffusion coefficient maps for assessment of tumor response. Radiology 2012; 264: 285-294.
2. Guglielmi A, Ruzzenente A, Campagnaro T, Pachera S, Valdegamberi A, Nicoli P, Cappellani A, Malfermoni G and Iacono C. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection. World J Surg 2009; 33: 1247-1254.
3. Shi W and Harris AL. Notch signaling in breast cancer and tumor angiogenesis: cross-talk and therapeutic potentials. J Mammary Gland Biol Neoplasia 2006; 11: 41-52.
4. Weinmaster G. Notch signaling: direct or what? Curr Opin Genet Dev 1998; 8: 436-442.
5. Rand MD, Grimm LM, Artavanis-Tsakonas S, Patriub V, Blacklow SC, Sklar J and Aster JC. Calcium depletion dissociates and activates heterodimeric notch receptors. Mol Cell Biol 2000; 20: 1825-1835.
6. Das I, Craig C, Funahashi Y, Jung KM, Kim TW, Byers R, Weng AP, Kutok JL, Aster JC and Kitajewski J. Notch oncoproteins depend on gamma-secretase/presenilin activity for processing and function. J Biol Chem 2004; 279: 30771-30780.
7. Yoon HA, Noh MH, Kim BG, Han JS, Jang JS, Choi SR, Jeong JS and Chun JH. Clinicopathological significance of altered Notch signaling in extrahepatic cholangiocarcinoma and gallbladder carcinoma. World J Gastroenterol 2011; 17: 4023-4030.
8. Shao H, Huang Q and Liu ZJ. Targeting Notch signaling for cancer therapeutic intervention. Adv Pharmacol 2012; 65: 191-234.
9. Brennan K and Clarke RB. Combining Notch inhibition with current therapies for breast cancer treatment. Ther Adv Med Oncol 2013; 5: 17-24.
10. Dumont AG, Yang Y, Reynoso D, Katz D, Trent JC and Hughes DP. Anti-tumor effects of the Notch pathway in gastrointestinal stromal tumors. Carcinogenesis 2012; 33: 1674-1683.
11. Yabuuchi S, Pai SG, Campbell NR, de Wilde RF, De Oliveira E, Korangath P, Streppel MM, Rasheed ZA, Hidalgo M, Maitra A and Rajeshkumar NV. Notch signaling pathway targeted therapy suppresses tumor progression and metastatic spread in pancreatic cancer. Cancer Lett 2013; 335: 41-51.
12. Ye QF, Zhang YC, Peng XQ, Long Z, Ming YZ and He LY. siRNA-mediated silencing of Notch-1 enhances docetaxel induced mitotic arrest and apoptosis in prostate cancer cells. Asian Pac J Cancer Prev 2012; 13: 2485-2489.
13. Yu S, Zhang R, Liu F, Wang H, Wu J and Wang Y. Notch inhibition suppresses nasopharyngeal carcinoma by depleting cancer stem-like side population cells. Oncol Rep 2012; 28: 561-566.
14. Zhu H, Zhou X, Redfield S, Lewin J and Miele L. Elevated Jagged-1 and Notch-1 expression in high grade and metastatic prostate cancers. Am J Transl Res 2013; 5: 368-378.
15. Ahn S, Hyeon J and Park CK. Notch1 and Notch4 are markers for poor prognosis of hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2013; 12: 286-294.
16. Sekiya S and Suzuki A. Intrahepatic cholangiocarcinoma can arise from Notch-mediated conversion of hepatocytes. J Clin Invest 2012; 122: 3914-3918.
17. Fan B, Malato Y, Calvisi DF, Naqvi S, Razumilava N, Ribback S, Gores GJ, Dombrowski F, Evert M, Chen X and Willenbring H. Cholangiocarcinomas can originate from hepatocytes in mice. J Clin Invest 2012; 122: 2911-2915.
18. Zhou Q, Wang Y, Peng B, Liang L and Li J. The roles of Notch1 expression in the migration of intrahepatic cholangiocarcinoma. BMC Cancer 2013; 13: 244.
19. Higashi M, Yamada N, Yokoyama S, Kitamoto S, Tabata K, Koriyama C, Batra SK and Yonezawa S. Pathobiological implications of MU-C16/CA125 expression in intrahepatic cholangiocarcinoma-mass forming type. Pathobiology 2012; 79: 101-106.
20. Tchorz JS, Kinter J, Muller M, Tornillo L, Heim MH and Bettler B. Notch2 signaling promotes biliary epithelial cell fate specification and tubulogenesis during bile duct development in mice. Hepatology 2009; 50: 871-879.
21. Trehanpati N, Shrivastav S, Shivakumar B, Khosla R, Bhardwaj S, Chaturvedi J, Sukriti, Kumar B, Bose S, Mani Tripathi D, Das T, Sakhuja P, Rastogi A, Bhihari C, Singh S, Gupta S, Kottilil S and Sarin SK. Analysis of Notch and TGF-beta Signaling Expression in Different Stages of Disease Progression During Hepatitis B Virus Infection. Clin Transl Gastroenterol 2012; 3: e23.
22. Pei J, Tang Z, Zang G and Yu Y. Blockage of Notch1 signaling modulates the T-helper (Th)1/Th2 cell balance in chronic hepatitis B patients. Hepatol Res 2010; 40: 799-805.